Clinical Trials Browser

Interventional × Prostatic Neoplasms × Panitumumab × Clear all

NCT00054574 2020-08-03

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00425204 2008-09-15

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Phase 2 Completed

GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Colorectal Neoplasms

NCT00061126 2005-06-24

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Phase 2 Completed

Prostatic Neoplasms